The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
von Hippel–Lindau disease: A clinical and scientific review
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Self-citationHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
Self-citationMutations of the VHL tumour suppressor gene in renal carcinoma
Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730
Rini, B. I., Campbell, S. C., & Escudier, B. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60229-4 · Cited by 1,621
Lonser, R. R., Glenn, G. M., Walther, M., Chew, E. Y., Libutti, S. K., Linehan, W. M., & Oldfield, E. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13643-4 · Cited by 1,600
Germ-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B. U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,367
Self-citationClinical Features and Natural History of von Hippel-Lindau Disease
MAHER, E. R., YATES, J. R. W., HARRIES, R., BENJAMIN, C., HARRIS, R., MOORE, A. T., & FERGUSON-SMITH, M. A. (1990) · QJM · doi:10.1093/qjmed/77.2.1151 · Cited by 937
Self-citationStructure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function
Stebbins, C. E., Kaelin, W. G., & Pavletich, N. P. (1999) · Science · doi:10.1126/science.284.5413.455 · Cited by 860
Rbx1, a Component of the VHL Tumor Suppressor Complex and SCF Ubiquitin Ligase
Kamura, T., Koepp, D. M., Conrad, M. N., Skowyra, D., Moreland, R. J., Iliopoulos, O., Lane, W. S., Kaelin, W. G., Elledge, S. J., Conaway, R. C., et al. (1999) · Science · doi:10.1126/science.284.5414.657 · Cited by 781
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
Kondo, K., Klco, J., Nakamura, E., Lechpammer, M., & Kaelin, W. G. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00043-0 · Cited by 761
Von Hippel-Lindau disease: a genetic study.
Maher, E. R., Iselius, L., Yates, J. R., Littler, M., Benjamin, C., Harris, R., Sampson, J., Williams, A., Ferguson-Smith, M. A., & Morton, N. (1991) · Journal of Medical Genetics · doi:10.1136/jmg.28.7.443 · Cited by 595
Self-citationChen, F., Kishida, T., Yao, M., Hustad, T., Glavac, D., Dean, M., Gnarra, J. R., Orcutt, M. L., Duh, F. M., Glenn, G., et al. (1995) · Human Mutation · doi:10.1002/humu.1380050109 · Cited by 556
Lee, S., Nakamura, E., Yang, H., Wei, W., Linggi, M. S., Sajan, M. P., Farese, R. V., Freeman, R. S., Carter, B. D., Kaelin, W. G., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.015 · Cited by 527
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
Ang, S. O., Chen, H., Hirota, K., Gordeuk, V. R., Jelinek, J., Guan, Y., Liu, E., Sergueeva, A. I., Miasnikova, G. Y., Mole, D., et al. (2002) · Nature Genetics · doi:10.1038/ng1019 · Cited by 510
HIF activation identifies early lesions in VHL kidneys
Mandriota, S. J., Turner, K. J., Davies, D. R., Murray, P. G., Morgan, N. V., Sowter, H. M., Wykoff, C. C., Maher, E. R., Harris, A. L., Ratcliffe, P. J., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00071-5 · Cited by 483
Self-citationWanebo, J. E., Lonser, R. R., Glenn, G. M., & Oldfield, E. H. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.98.1.0082 · Cited by 467
Maranchie, J. K., Vasselli, J. R., Riss, J., Bonifacino, J. S., Linehan, W. M., & Klausner, R. D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00044-2 · Cited by 432
Pancreatic involvement in von Hippel–Lindau disease
Hammel, P. R., Vilgrain, V., Terris, B., Penfornis, A., Sauvanet, A., Correas, J., Chauveau, D., Balian, A., Beigelman, C., O'Toole, D., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.18143 · Cited by 426
Self-citationA.Crossey, P., M.Richards, F., Foster, K., reen, J. S., Prowse, A., Latlf, F., Lerman, M. I., Zbar, B., Atfara, N. A., Ferguson-Smith, M. A., et al. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.8.1303 · Cited by 382
Self-citationHoffman, M. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1019 · Cited by 382
Clifford, S. C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1029 · Cited by 373
Foster, K., Prowse, A., van den Berg, A., Fleming, S., Hulsbeek, M. M. F., Crossey, P. A., Richards, F. M., Cairns, P., Affara, N. A., Ferguson-Smith, M. A., et al. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.12.2169 · Cited by 373
Self-citationEisenhofer, G., Lenders, J. W. M., Linehan, W. M., Walther, M. M., Goldstein, D. S., & Keiser, H. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402404 · Cited by 349
Genetic analysis of von Hippel-Lindau disease
Nordstrom-O'Brien, M., van der Luijt, R. B., van Rooijen, E., van den Ouweland, A. M., Majoor-Krakauer, D. F., Lolkema, M. P., van Brussel, A., Voest, E. E., & Giles, R. H. (2010) · Human Mutation · doi:10.1002/humu.21219 · Cited by 311
Banks, R. E., Tirukonda, P., Taylor, C., Hornigold, N., Astuti, D., Cohen, D., Maher, E. R., Stanley, A. J., Harnden, P., Joyce, A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3074 · Cited by 275
Self-citationGordeuk, V. R., Sergueeva, A. I., Miasnikova, G. Y., Okhotin, D., Voloshin, Y., Choyke, P. L., Butman, J. A., Jedlickova, K., Prchal, J. T., & Polyakova, L. A. (2004) · Blood · doi:10.1182/blood-2003-07-2535 · Cited by 273
Iliopoulos, O., Ohh, M., & Kaelin, W. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11661 · Cited by 260
Genotype-phenotype correlations in von Hippel-Lindau disease
Ong, K. R., Woodward, E. R., Killick, P., Lim, C., Macdonald, F., & Maher, E. R. (2007) · Human Mutation · doi:10.1002/humu.20385 · Cited by 250
Self-citationWALTHER, M. M., CHOYKE, P. L., GLENN, G., LYNE, J. C., RAYFORD, W., VENZON, D., & LINEHAN, W. M. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68930-6 · Cited by 249
Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease
Manski, T. J. (1997) · JAMA · doi:10.1001/jama.277.18.1461 · Cited by 239
Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.
Maher, E. R., Webster, A. R., Richards, F. M., Green, J. S., Crossey, P. A., Payne, S. J., & Moore, A. T. (1996) · Journal of Medical Genetics · doi:10.1136/jmg.33.4.328 · Cited by 229
Self-citationSurgical management of brainstem hemangioblastomas in patients with von Hippel—Lindau disease
Weil, R. J., Lonser, R. R., Devroom, H. L., Wanebo, J. E., & Oldfield, E. H. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.98.1.0095 · Cited by 220
Endolymphatic Sac Tumors: A Source of Morbid Hearing Loss in von Hippel-Lindau Disease
Manski, T. J. (1997) · JAMA · doi:10.1001/jama.1997.03540420057030 · Cited by 203
The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients.
Choyke, P. L., Glenn, G. M., Walther, M. M., Zbar, B., Weiss, G. H., Alexander, R. B., Hayes, W. S., Long, J. P., Thakore, K. N., & Linehan, W. M. (1992) · American Journal of Roentgenology · doi:10.2214/ajr.159.6.1442389 · Cited by 198
NEUMANN, H. P. H., BENDER, B. U., BERGER, D. P., LAUBENBERGER, J., SCHULTZE-SEEMANN, W., WETTERAUER, U., FERSTL, F. J., HERBST, E. W., SCHWARZKOPF, G., HES, F. J., et al. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)62509-6 · Cited by 183
Self-citationBrauch, H., Kishida, T., Glavac, D., Chen, F., Pausch, F., Höfler, H., Latif, F., Lerman, M. I., Zbar, B., & P. H. Neumann, H. (1995) · Human Genetics · doi:10.1007/bf00223868 · Cited by 180
Maher, E. R., Yates, J. R., & Ferguson-Smith, M. A. (1990) · Journal of Medical Genetics · doi:10.1136/jmg.27.5.311 · Cited by 177
Self-citationCentral nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease
Richard, S., David, P., Marsot-Dupuch, K., Giraud, S., Béroud, C., & Resche, F. (2000) · Neurosurgical Review · doi:10.1007/s101430050024 · Cited by 153
Self-citationRetinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study.
Dollfus, H., Massin, P., Taupin, P., Nemeth, C., Amara, S., Giraud, S., Béroud, C., Dureau, P., Gaudric, A., Landais, P., et al. (2002) · PubMed · Cited by 147
Self-citationZatyka, M., da Silva, N. F., Clifford, S. C., Morris, M. R., Wiesener, M. S., Eckardt, K., Houlston, R. S., Richards, F. M., Latif, F., & Maher, E. R. (2002) · PubMed · doi:10.25405/ncl.34582002 · Cited by 147
Self-citationMaher, E. R. (2004) · Current Molecular Medicine · doi:10.2174/1566524043359827 · Cited by 142
Self-citationHead and Neck Paragangliomas in Von Hippel-Lindau Disease and Multiple Endocrine Neoplasia Type 2
Boedeker, C. C., Erlic, Z., Richard, S., Kontny, U., Gimenez‐Roqueplo, A., Cascón, A., Robledo, M., de Campos, J. M., van Nederveen, F. H., de Krijger, R. R., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0354 · Cited by 138
Self-citationPark, D. M., Zhuang, Z., Chen, L., Szerlip, N. J., Marić, I., Li, J., Sohn, T., Kim, S. H., Lubensky, I. A., Vortmeyer, A. O., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040060 · Cited by 134
Jiménez, C., Cabanillas, M. E., Santarpia, L., Jonasch, E. W., Kyle, K. L., Lano, E. A., Matin, S. F., NUÑEZ, R. F., Perrier, N. D., Phan, A. T., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1972 · Cited by 133
Treatment of kidney cancer: Insights Provided by the VHL Tumor‐Suppressor Protein
Kaelin, W. G. (2009) · Cancer · doi:10.1002/cncr.24232 · Cited by 129
Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL
Woodward, E. R., Eng, C., McMahon, R., Voutilainen, R., Affara, N. A., Ponder, B., & Maher, E. R. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.7.1051 · Cited by 129
Self-citationRichard, S., Graff, J., Lindau, J., & Resche, F. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15957-6 · Cited by 127
Self-citationFranke, G., Bausch, B., Hoffmann, M. M., Cybulla, M., Wilhelm, C., Kohlhase, J., Scherer, G., & Neumann, H. P. H. (2009) · Human Mutation · doi:10.1002/humu.20948 · Cited by 124
Self-citationImmunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues
Corless, C. L., Kibel, A. S., Iliopoulos, O., & Kaelin, W. G. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90035-6 · Cited by 121
Neumann, H. P. H., Reincke, M., Bender, B., Elsner, R., & Janetschek, G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5872 · Cited by 118
Self-citationEpididymal cystadenomas in von Hippel-Lindau disease
Choyke, P. L., Glenn, G. M., Wagner, J. P., et al. (1997) · Urology · doi:10.1016/s0090-4295(97)00074-5 · Cited by 113
Girmens, J., Erginay, A., Massin, P., et al. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00101-6 · Cited by 112
Walz, M. K., Peitgen, K., Neumann, H. P. H., Janssen, O. E., Philipp, T., & Mann, K. (2002) · World Journal of Surgery · doi:10.1007/s00268-002-6632-x · Cited by 110
Self-citationExpression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis
Richards, F., Schofield, P. N., Fleming, S., & Maher, E. R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.5.639 · Cited by 104
Self-citationMaranchie, J. K., Afonso, A. M., Albert, P. S., Kalyandrug, S., Phillips, J. L., Zhou, S., Peterson, J. C., Ghadimi, Β. M., Hurley, K., Riss, J., et al. (2003) · Human Mutation · doi:10.1002/humu.10302 · Cited by 98
Webster, A. R., Richards, F. M., MacRonald, F. E., Moore, A. T., & Maher, E. R. (1998) · The American Journal of Human Genetics · doi:10.1086/302037 · Cited by 98
Self-citationEndocrine Pancreatic Tumors in von Hippel-Lindau Disease
Corcos, O., Couvelard, A., Giraud, S., Vullierme, M., O’Toole, D., Rebours, V., Stiévenart, J.-L., Penfornis, A., Niccoli, P., Baudin, É., et al. (2008) · Pancreas · doi:10.1097/mpa.0b013e31815f394a · Cited by 95
Self-citationVon Hippel-Lindau disease and endocrine tumour susceptibility
Woodward, E. R., & Maher, E. R. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.00683 · Cited by 90
Self-citationGoldfarb, D. A., Neumann, H. P. H., Penn, I., & Novick, A. C. (1997) · Transplantation · doi:10.1097/00007890-199712270-00017 · Cited by 79
Self-citationThe worldwide distribution of the VHL 598C>T mutation indicates a single founding event
Liu, E., Percy, M. J., Amos, C. I., Guan, Y., Shete, S., Stockton, D. W., McMullin, M. F., Polyakova, L. A., Ang, S. O., Pastore, Y. D., et al. (2004) · Blood · doi:10.1182/blood-2003-07-2550 · Cited by 66
Maher, E. R., & Moore, A. (1992) · British Journal of Ophthalmology · doi:10.1136/bjo.76.12.743 · Cited by 65
Self-citationComparative Sequence Analysis of the VHL Tumor Suppressor Gene
Woodward, E. R., Buchberger, A., Clifford, S. C., Hurst, L. D., Affara, N. A., & Maher, E. R. (2000) · Genomics · doi:10.1006/geno.2000.6144 · Cited by 59
Self-citationPsychosocial impact of Von Hippel–Lindau disease: levels and sources of distress
Lammens, C. R. M., Bleiker, E. M. A., Verhoef, S., Hes, F. J., Ausems, M. G. E. M., Majoor‐Krakauer, D. F., Sijmons, R. H., van der Luijt, R. B., Ouweland, A. V. D., Os, T. V., et al. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01333.x · Cited by 59
Clustering of features and genetics of von Hippel-Lindau syndrome
Neumann, H. H. (1991) · The Lancet · doi:10.1016/0140-6736(91)90401-a · Cited by 52
Self-citationCascón, A., Escobar, B., Montero‐Conde, C., Rodríguez‐Antona, C., Ruiz‐Llorente, S., Osório, A., Mercadillo, F., Letón, R., de Campos, J. M., García‐Sagredo, J. M., et al. (2007) · Human Mutation · doi:10.1002/humu.20496 · Cited by 46
Ricketts, C. J., Zeegers, M. P., Lubiński, J., & Maher, E. R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006037 · Cited by 43
Self-citation
Cited by
Epidemiology of Renal Cell Carcinoma
Padala, S. A., Barsouk, A., Thandra, K. C., Saginala, K., Mohammed, A., Vakiti, A., Rawla, P., & Barsouk, A. (2020) · World Journal of Oncology · doi:10.14740/wjon1279 · Cited by 1,058
VHL, the story of a tumour suppressor gene
Gossage, L., Eisen, T., & Maher, E. R. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3844 · Cited by 774
Self-citationBelzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease
Jonasch, E., Donskov, F., Iliopoulos, O., Rathmell, W. K., Narayan, V. K., Maughan, B. L., Oudard, S., Else, T., Maranchie, J. K., Welsh, S. J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2103425 · Cited by 714
A Lactate-Induced Response to Hypoxia
Lee, D. C., Sohn, H. A., Park, Z.-Y., Oh, S., Kang, Y. K., Lee, K.-M., Kang, M., Jang, Y. J., Yang, S.-J., Hong, Y. K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.011 · Cited by 520
Paraganglioma and phaeochromocytoma: from genetics to personalized medicine
Favier, J., Amar, L., & Gimenez-Roqueplo, A.-P. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.188 · Cited by 490
Metadata
- Authors
- Maher, E. R., Neumann, H. P., & Richard, S.
- Venue
- European Journal of Human Genetics
- Published
- 2011-03-09
- Volume
- 19
- Issue
- 6
- Pages
- 617-623
- ISSN
- 1018-4813 (ISSN-L)
- 1476-5438
- OpenAlex
- W2011499154
- Cited by
- 729
- References
- 69
- FWCI
- 18.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.